Clinical Study
Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes
Table 2
Dose, fractionation schedules, and treatment groups.
| Treatment intent | Prescription dose | Number of fractions | Number of patients (%) | No ADT | ADT | Total |
| Definitive VMAT | | | | | | Intermediate risk | 74 Gy | 37 | 5 | 4 | 9 | High risk | 78 Gy | 39 | 1 | 15 | 16 | Total | — | — | 6 (5%) | 19 (17%) | 25 (22%) | VMAT following HDR brachytherapy | 50.4 Gy | 28 | 9 (8%) | 16 (14%) | 25 (22%) | Salvage VMAT | 66 Gy | 33 | 38 (34%) | 11 (10%) | 49 (44%) | Adjuvant VMAT | 66 Gy | 33 | 9 (8%) | 5 (4%) | 14 (12%) | Total | — | — | 62 (55%) | 51 (45%) | 113 (100%) |
|
|